Funding
Funding not disclosed
Founders
Product
Problem
Many short-term medical procedures require sedation and analgesia, often relying on traditional methods that can lead to prolonged recovery times and the need for extensive patient monitoring. These methods may not always be optimal for patient comfort and safety during shorter interventions.
Solution
Melt Pharmaceuticals is developing a novel approach to procedural sedation and analgesia tailored for short-term medical procedures. Their method focuses on improving patient comfort and safety while significantly reducing recovery time and minimizing the need for extended post-procedure monitoring. This innovative solution aims to provide a more efficient and patient-friendly experience during brief medical interventions.
Target Audience
The primary target audience includes healthcare providers and medical facilities performing short-term medical procedures, such as endoscopies, biopsies, and minor surgeries.
Features
- Novel drug formulation designed for rapid onset and offset of sedation and analgesia.
- Reduced need for post-procedure monitoring compared to traditional methods.
- Enhanced patient comfort during short-term medical procedures.